Literature DB >> 32320012

Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study.

Danni Li1, Jeffrey R Misialek2, Ma Jing3, Michael Y Tsai1, John H Eckfeldt1, Lyn M Steffen2, David Knopman4, Lisa Wruck5, Rebecca Gottesman6, Tom H Mosley7, A Richey Sharrett8, Alvaro Alonso9.   

Abstract

BACKGROUND: Very-long-chain SFAs (VLSFAs) have recently gained considerable attention as having beneficial effects on health and aging.
OBJECTIVES: The objective of this study was to assess the associations of plasma phospholipid VLSFAs [arachidic acid (20:0), behenic acid (22:0), tricosanoic acid (23:0), and lignoceric acid (24:0)] with 20-y cognitive decline in the Atherosclerosis Risk in Communities (ARIC) participants. Furthermore, this study compared the associations of plasma phospholipid VLSFAs with 5 common groups of fatty acids [i.e., total SFAs, total MUFAs, total ω-3 (n-3) PUFAs, total marine-derived ω-3 PUFAs, total ω-6 PUFAs].
METHODS: This study used a cohort study design of 3229 ARIC participants enrolled at the Minnesota field center. Fatty acids were measured at visit 1 (1987-1989); and cognition was assessed at visits 2 (1990-1992), 4 (1996-1998), and 5 (2011-2013) using 3 tests: the Delayed Word Recall Test (DWRT), the Digit-Symbol Substitution Test (DSST), and the Word Fluency Test (WFT).
RESULTS: Higher proportions of plasma phospholipid total VLSFAs and each individual VLSFA were associated with less decline in WFT, a test of verbal fluency. For example, 1 SD higher in total VLSFAs at baseline was associated with 0.057 SD (95% CI: 0.018, 0.096, P = 0.004) less cognitive decline over 20 y as measured by WFT score. None of the 5 common fatty acid groups were associated with change in WFT, but a higher proportion of plasma phospholipid total MUFAs was associated with greater decline in DWRT; higher total ω-6 PUFAs with less decline in DWRT; and higher total ω-3 and total marine-derived ω-3 PUFAs with less decline in DSST.
CONCLUSIONS: This study suggests that higher proportions of plasma phospholipid VLSFAs in midlife may be associated with less 20-y cognitive decline.
Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.

Entities:  

Keywords:  Delayed Word Recall Test (DWRT); Digit-Symbol Substitution Test (DSST); Word Fluency Test (WFT); cognitive change; midlife; plasma phospholipid very-long-chain saturated fatty acids (VLSFAs)

Mesh:

Substances:

Year:  2020        PMID: 32320012      PMCID: PMC7266687          DOI: 10.1093/ajcn/nqaa048

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  33 in total

1.  High monounsaturated fatty acids intake protects against age-related cognitive decline.

Authors:  V Solfrizzi; F Panza; F Torres; F Mastroianni; A Del Parigi; A Venezia; A Capurso
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

2.  Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.

Authors:  Patty W Siri-Tarino; Qi Sun; Frank B Hu; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2010-01-13       Impact factor: 7.045

3.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

Authors:  J A Baecke; J Burema; J E Frijters
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

4.  Relation of smoking and alcohol consumption to serum fatty acids.

Authors:  J A Simon; J Fong; J T Bernert; W S Browner
Journal:  Am J Epidemiol       Date:  1996-08-15       Impact factor: 4.897

5.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study.

Authors:  Barbara Heude; Pierre Ducimetière; Claudine Berr
Journal:  Am J Clin Nutr       Date:  2003-04       Impact factor: 7.045

6.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Authors:  Sandrine Andrieu; Sophie Guyonnet; Nicola Coley; Christelle Cantet; Marc Bonnefoy; Serge Bordes; Lawrence Bories; Marie-Noëlle Cufi; Thierry Dantoine; Jean-François Dartigues; Françoise Desclaux; Audrey Gabelle; Yannick Gasnier; Alain Pesce; Kristel Sudres; Jacques Touchon; Philippe Robert; Olivier Rouaud; Philippe Legrand; Pierre Payoux; Jean-Paul Caubere; Michael Weiner; Isabelle Carrié; Pierre-Jean Ousset; Bruno Vellas
Journal:  Lancet Neurol       Date:  2017-03-27       Impact factor: 44.182

Review 7.  Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.

Authors:  Majid Fotuhi; Payam Mohassel; Kristine Yaffe
Journal:  Nat Clin Pract Neurol       Date:  2009-03

8.  ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA.

Authors:  Eric M Ammann; James V Pottala; William S Harris; Mark A Espeland; Robert Wallace; Natalie L Denburg; Ryan M Carnahan; Jennifer G Robinson
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

9.  Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.

Authors:  Boukje Maria van Gelder; Marja Tijhuis; Sandra Kalmijn; Daan Kromhout
Journal:  Am J Clin Nutr       Date:  2007-04       Impact factor: 7.045

10.  Impact of methods used to express levels of circulating fatty acids on the degree and direction of associations with blood lipids in humans.

Authors:  Susan Sergeant; Ingo Ruczinski; Priscilla Ivester; Tammy C Lee; Timothy M Morgan; Barbara J Nicklas; Rasika A Mathias; Floyd H Chilton
Journal:  Br J Nutr       Date:  2015-11-30       Impact factor: 3.718

View more
  6 in total

1.  Serum ω-3 Fatty Acids and Cognitive Domains in Community-Dwelling Older Adults from the NuAge Study: Exploring the Associations with Other Fatty Acids and Sex.

Authors:  Caroline S Duchaine; Alexandra J Fiocco; Pierre-Hugues Carmichael; Stephen C Cunnane; Mélanie Plourde; Aurélie Lampuré; Benjamin Allès; Sylvie Belleville; Pierrette Gaudreau; Nancy Presse; Guylaine Ferland; Danielle Laurin
Journal:  J Nutr       Date:  2022-09-06       Impact factor: 4.687

2.  Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.

Authors:  Yu Jia; Dongze Li; Jing Yu; Yi Liu; Fanghui Li; Wentao Li; Qin Zhang; Yongli Gao; Wei Zhang; Zhi Zeng; Rui Zeng; Xiaoyang Liao; Qian Zhao; Zhi Wan
Journal:  BMC Geriatr       Date:  2022-04-12       Impact factor: 3.921

Review 3.  Very long-chain saturated fatty acids and diabetes and cardiovascular disease.

Authors:  Rozenn N Lemaitre; Irena B King
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.616

Review 4.  Macrophage-Mediated Immune Responses: From Fatty Acids to Oxylipins.

Authors:  Barbara Balestrieri; David Di Costanzo; Daniel F Dwyer
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

5.  Cognition impairment and risk of subclinical cardiovascular disease in older adults: The atherosclerosis risk in communities study.

Authors:  Dongze Li; Yu Jia; Jing Yu; Yi Liu; Fanghui Li; Wei Zhang; Yongli Gao; Xiaoyang Liao; Zhi Wan; Zhi Zeng; Rui Zeng
Journal:  Front Aging Neurosci       Date:  2022-07-27       Impact factor: 5.702

6.  Silent Myocardial Infarction and Long-Term Risk of Frailty: The Atherosclerosis Risk in Communities Study.

Authors:  Fanghui Li; Dongze Li; Jing Yu; Yu Jia; Yi Liu; Yanmei Liu; Qinqin Wu; Xiaoyang Liao; Zhi Zeng; Zhi Wan; Rui Zeng
Journal:  Clin Interv Aging       Date:  2021-06-18       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.